COVID-19 in New South Wales children during 2021: severity and clinical spectrum.


Journal

The Medical journal of Australia
ISSN: 1326-5377
Titre abrégé: Med J Aust
Pays: Australia
ID NLM: 0400714

Informations de publication

Date de publication:
19 09 2022
Historique:
revised: 17 05 2022
received: 04 01 2022
accepted: 18 05 2022
pubmed: 20 7 2022
medline: 21 9 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

To describe the severity and clinical spectrum of coronavirus disease 2019 (COVID-19) in children during the 2021 New South Wales outbreak of the Delta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Prospective cohort study in three metropolitan Sydney local health districts, 1 June - 31 October 2021. Children under 16 years of age with positive SARS-CoV-2 nucleic acid test results admitted to hospital or managed by the Sydney Children's Hospital Network (SCHN) virtual care team. Age-specific SARS-CoV-2 infection frequency, overall and separately for SCHN virtual and hospital patients; rates of medical and social reason admissions, intensive care admissions, and paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 per 100 SARS-CoV-2 infections; demographic and clinical factors that influenced likelihood of hospital admission. A total of 17 474 SARS-CoV-2 infections in children under 16 were recorded in NSW, of whom 11 985 (68.6%) received SCHN-coordinated care, including 459 admitted to SCHN hospitals: 165 for medical reasons (1.38 [95% CI, 1.17-1.59] per 100 infections), including 15 admitted to intensive care, and 294 (under 18 years of age) for social reasons (2.45 [95% CI, 2.18-2.73] per 100 infections). In an analysis that included all children admitted to hospital and a random sample of those managed by the virtual team, having another medical condition (adjusted odds ratio [aOR], 7.42; 95% CI, 3.08-19.3) was associated with increased likelihood of medical admission; in univariate analyses, non-asthmatic chronic respiratory disease was associated with greater (OR, 9.21; 95% CI, 1.61-174) and asthma/viral induced wheeze with lower likelihood of admission (OR, 0.38; 95% CI, 0.18-0.78). The likelihood of admission for medical reasons declined from infancy to 5-11 years, but rose again for those aged 12-15 years. Sex and Indigenous status did not influence the likelihood of admission. Most SARS-CoV-2 infections (Delta variant) in children were asymptomatic or associated with mild disease. Hospitalisation was relatively infrequent, and most common for infants, adolescents, and children with other medical conditions. More children were hospitalised for social than for medical reasons.

Identifiants

pubmed: 35851698
doi: 10.5694/mja2.51661
pmc: PMC9349636
doi:

Substances chimiques

Nucleic Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-310

Subventions

Organisme : Australian Commonwealth Department of Health
Organisme : National Health and Medical Research Council
Organisme : NSW Ministry of Health

Informations de copyright

© 2022 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.

Références

Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Pediatrics. 2012 Dec;130(6):e1455-62
pubmed: 23129086
J Paediatr Child Health. 2022 Apr;58(4):618-623
pubmed: 34693586
Med J Aust. 2022 Jul 4;217(1):43-45
pubmed: 35598097
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915968
Nat Rev Immunol. 2021 Apr;21(4):202-203
pubmed: 33623123
BMJ. 2020 Apr 28;369:m1669
pubmed: 32345583
PLoS One. 2021 Mar 4;16(3):e0247461
pubmed: 33661992
Nat Commun. 2022 Apr 29;13(1):2356
pubmed: 35487905
Arch Dis Child. 2020 Dec 17;:
pubmed: 33334728
N Engl J Med. 2022 Jul 14;387(2):109-119
pubmed: 35731908
Hosp Pediatr. 2021 Aug;11(8):e151-e156
pubmed: 34011566
Hosp Pediatr. 2021 Aug;11(8):e133-e141
pubmed: 34011567
BMJ Open. 2021 Nov 8;11(11):e054510
pubmed: 34750151
Med J Aust. 2021 Sep 6;215(5):217-221
pubmed: 34389995
BMJ. 2020 Aug 27;370:m3249
pubmed: 32960186
Nat Med. 2022 Jan;28(1):185-192
pubmed: 34764489
Lancet Child Adolesc Health. 2021 Oct;5(10):708-718
pubmed: 34358472
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Int J Environ Res Public Health. 2021 Mar 26;18(7):
pubmed: 33810225

Auteurs

Phoebe Williams (P)

The Children's Hospital at Westmead, Sydney, NSW.
Sydney Children's Hospital at Randwick, Sydney, NSW.

Archana Koirala (A)

The University of Sydney, Sydney, NSW.
National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.

Gemma L Saravanos (GL)

Kids Research, the Sydney Children's Hospitals Network, Sydney, NSW.

Laura K Lopez (LK)

National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.

Catherine Glover (C)

National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.

Ketaki Sharma (K)

The University of Sydney, Sydney, NSW.
National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.

Tracey Williams (T)

The Children's Hospital at Westmead, Sydney, NSW.
Home in the Hospital service, the Sydney Children's Hospitals Network, Sydney, NSW.

Emma Carey (E)

Kids Research, the Sydney Children's Hospitals Network, Sydney, NSW.

Nadine Shaw (N)

virtualKIDS, the Sydney Children's Hospitals Network, Sydney, NSW.

Emma Dickens (E)

virtualKIDS, the Sydney Children's Hospitals Network, Sydney, NSW.

Neela Sitaram (N)

virtualKIDS, the Sydney Children's Hospitals Network, Sydney, NSW.

Joanne Ging (J)

virtualKIDS, the Sydney Children's Hospitals Network, Sydney, NSW.

Paula Bray (P)

Kids Research, the Sydney Children's Hospitals Network, Sydney, NSW.
Home in the Hospital service, the Sydney Children's Hospitals Network, Sydney, NSW.

Nigel W Crawford (NW)

Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, VIC.
Royal Children's Hospital Melbourne, Melbourne, VIC.

Brendan McMullan (B)

Royal Children's Hospital Melbourne, Melbourne, VIC.
The University of New South Wales, Sydney, NSW.

Kristine Macartney (K)

The University of Sydney, Sydney, NSW.
National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.

Nicholas Wood (N)

The Children's Hospital at Westmead, Sydney, NSW.
The University of Sydney, Sydney, NSW.

Elizabeth L Fulton (EL)

The Children's Hospital at Westmead, Sydney, NSW.
Home in the Hospital service, the Sydney Children's Hospitals Network, Sydney, NSW.

Christine Lau (C)

virtualKIDS, the Sydney Children's Hospitals Network, Sydney, NSW.

Philip N Britton (PN)

The Children's Hospital at Westmead, Sydney, NSW.
The University of Sydney, Sydney, NSW.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH